Option Care Health price target lowered to $32 from $38 at Citizens

Citizens lowered the firm’s price target on Option Care Health (OPCH) to $32 from $38 and keeps an Outperform rating on the shares. The firm said there are “a lot of moving pieces,” but it ultimately believes Option’s current challenges remain confined to a particular therapeutic category, which was a sizable franchise that historically contributed to the company’s profitability in a disproportionate manner prior to the introduction of a multitude of biosimilars.